Multimodal Data-assisted Primary Screening for Allergic Rhinitis Based on Voice Recognition and Face Recognition

Launched by ZHENG LIU · Jun 19, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating a new way to help diagnose allergic rhinitis, which is a condition that causes sneezing, runny nose, and other allergy symptoms. Researchers are using advanced technology to collect images of patients' faces and recordings of their voices, along with detailed medical examinations. By looking at this information, they aim to create a model that can better predict what type of rhinitis a patient has, helping doctors provide more effective treatments.

To participate in this study, individuals must be between the ages of 8 and 80, be of Chinese nationality, and have been diagnosed with chronic rhinitis. Participants will need to understand the study's purpose and agree to take part. However, certain individuals, such as those with serious health issues or who are pregnant, cannot join. If eligible, participants can expect to have their facial images and voice recorded, along with standard medical tests to identify specific allergens that may be causing their symptoms. This trial is currently recruiting, and those interested should consult with their healthcare provider for more information.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Subjects understood the purpose and procedure of the trial and signed an informed consent form, and voluntarily participated in this study;
• • 2. Subjects were initially clinically diagnosed with chronic rhinitis;
• • 3. Subjects were aged 8-80 years old, limited to Chinese nationality, and were able to perform basic examinations and cooperate with face photography and voice collection.
• Exclusion Criteria:
• • 1. Those who received systemic immunotherapy, used systemic or local glucocorticoids as well as leukotriene receptor antagonists within one month;
• • 2. Those who suffer from immune system diseases, autoimmune diseases, allergic diseases or allergies and have a history of food allergy;
• • 3. Other serious systemic diseases, such as active tuberculosis, rheumatic heart disease, congenital heart disease, arthritis, nephritis, hypertension, psychosis, dermatitis, epilepsy and so on;
• • 4. Women during lactation and pregnancy;
• • 5. History of upper respiratory tract infection or more serious infectious diseases within three months;
• • 6. Those who are currently participating in another clinical study or have participated in another clinical study within 90 days;
• • 7. Other patients who, in the judgment of the clinician, are not suitable for inclusion in the study.